Literature DB >> 9119549

The continuing increase in adenocarcinoma of the uterine cervix: a birth cohort phenomenon.

T Zheng1, T R Holford, Z Ma, Y Chen, W Liu, B A Ward, P Boyle.   

Abstract

BACKGROUND: Adenocarcinoma of the uterine cervix has been reported to be increasing among young white women and earlier studies suggest a birth cohort pattern for the observed increase. No study, however, has examined the time trends of adenocarcinoma of the cervix by birth cohort.
METHODS: Using Surveillance, Epidemiology, and End Results (SEER) data through 1990, the current study is designed to examine the time trends of invasive adenocarcinoma by birth cohort. An age-period-cohort model was fitted to the annual-age-specific rates to identify the components of birth cohort and time period as determinants of the observed time trends.
RESULTS: The results from this study clearly show that invasive adenocarcinoma of the uterine cervix has been increasing in both whites and blacks, but the increase is statistically significant only among whites, reaching 4.2 percent per year for those born since 1935. The results also show that the recent increase in invasive adenocarcinoma started among those born around the mid 1920s, and a strong birth cohort effect is largely responsible for the observed increase.
CONCLUSION: Invasive adenocarcinoma of the uterine cervix is increasing among recent birth cohorts. Analytical epidemiological studies are urgently needed to explore the risk factors responsible for the increase. The time trends for adenocarcinoma of the cervix should also be carefully monitored in the coming years.

Entities:  

Mesh:

Year:  1996        PMID: 9119549     DOI: 10.1093/ije/25.2.252

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  12 in total

1.  Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women.

Authors:  S Liu; R Semenciw; Y Mao
Journal:  CMAJ       Date:  2001-04-17       Impact factor: 8.262

2.  Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.

Authors:  E C Pirog; B Kleter; S Olgac; P Bobkiewicz; J Lindeman; W G Quint; R M Richart; C Isacson
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

3.  A birth cohort analysis of the incidence of adenocarcinoma of the uterine cervix in the USA.

Authors:  Cairong Zhu; Bryan A Bassig; Yawei Zhang; Kunchong Shi; Peter Boyle; Ni Li; Tongzhang Zheng
Journal:  Eur J Cancer Prev       Date:  2015-05       Impact factor: 2.497

4.  Preinvasive and Invasive Cervical Adenocarcinoma: Preceding Low-Risk or Negative Pap Result Increases Time to Diagnosis.

Authors:  Lea A Moukarzel; Ana M Angarita; Christopher VandenBussche; Anne Rositch; Carol B Thompson; Amanda N Fader; Kimberly Levinson
Journal:  J Low Genit Tract Dis       Date:  2017-04       Impact factor: 1.925

Review 5.  Vaccines for cervical cancer.

Authors:  C M Lowndes
Journal:  Epidemiol Infect       Date:  2006-02       Impact factor: 2.451

6.  The HPV Cellular Transactivator Brn-3a Can Be Used to Predict Cervical Adenocarcinoma and Squamous Carcinoma Precancer Lesions in the Developed and Developing Worlds.

Authors:  Daniel Ndisang; Felipe Lorenzato; Michael Sindos; Ashfaq Khan; Albert Singer; David S Latchman
Journal:  Obstet Gynecol Int       Date:  2010-03-09

7.  Prevalence, viral load, and physical status of HPV 16 and 18 in cervical adenosquamous carcinoma.

Authors:  Tomomi Yoshida; Takaaki Sano; Tetsunari Oyama; Tatsuya Kanuma; Toshio Fukuda
Journal:  Virchows Arch       Date:  2009-09       Impact factor: 4.064

8.  Subcellular localization of the human papillomavirus 16 E7 oncoprotein in CaSki cells and its detection in cervical adenocarcinoma and adenocarcinoma in situ.

Authors:  Kerstin Dreier; René Scheiden; Barbara Lener; Daniela Ehehalt; Haymo Pircher; Elisabeth Müller-Holzner; Ursula Rostek; Andreas Kaiser; Marc Fiedler; Sigrun Ressler; Stefan Lechner; Andreas Widschwendter; Jos Even; Catherine Capesius; Pidder Jansen-Dürr; Werner Zwerschke
Journal:  Virology       Date:  2010-10-23       Impact factor: 3.616

9.  Trends in cancer of the cervix uteri in Sweden following cytological screening.

Authors:  R Bergström; P Sparén; H O Adami
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

10.  HLA-E expression in cervical adenocarcinomas: association with improved long-term survival.

Authors:  Vivian M Spaans; Alexander A W Peters; Gert Jan Fleuren; Ekaterina S Jordanova
Journal:  J Transl Med       Date:  2012-09-04       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.